# Buprenorphine in the Emergency Department

> **NCT03174067** · PHASE4 · COMPLETED · sponsor: **St. Joseph's Health Centre Toronto** · enrollment: 26 (actual)

## Conditions studied

- Opioid Withdrawal
- Opioid-use Disorder

## Interventions

- **DRUG:** Buprenorphine
- **DRUG:** Clonidine

## Key facts

- **NCT ID:** NCT03174067
- **Lead sponsor:** St. Joseph's Health Centre Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2016-04
- **Final completion:** 2016-11
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2017-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03174067

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03174067, "Buprenorphine in the Emergency Department". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03174067. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*